Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Collegium Pharma (COLL)

Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 958,497
  • Shares Outstanding, K 32,132
  • Annual Sales, $ 631,450 K
  • Annual Income, $ 69,190 K
  • EBIT $ 139 M
  • EBITDA $ 306 M
  • 60-Month Beta 0.63
  • Price/Sales 1.52
  • Price/Cash Flow 2.40
  • Price/Book 4.06

Options Overview Details

View History
  • Implied Volatility 53.57% ( +0.79%)
  • Historical Volatility 27.58%
  • IV Percentile 28%
  • IV Rank 48.19%
  • IV High 81.10% on 04/07/25
  • IV Low 27.97% on 09/20/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 4
  • Volume Avg (30-Day) 3
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 379
  • Open Int (30-Day) 371

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 1.47
  • Number of Estimates 3
  • High Estimate 1.53
  • Low Estimate 1.43
  • Prior Year 1.43
  • Growth Rate Est. (year over year) +2.80%

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.34 +5.26%
on 05/23/25
30.93 -3.56%
on 06/10/25
-0.13 (-0.43%)
since 05/20/25
3-Month
23.23 +28.41%
on 04/10/25
30.93 -3.56%
on 06/10/25
-0.10 (-0.33%)
since 03/20/25
52-Week
23.23 +28.41%
on 04/10/25
42.29 -29.46%
on 10/07/24
-1.75 (-5.54%)
since 06/20/24

Most Recent Stories

More News
Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030

EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:NTRBW),(NYSE:PFE),(NASDAQ:COLL),(NYSE:TEVA),(NYSE:EBS) EQNX::TICKER_END

NTRB : 7.79 (unch)
NTRBW : 1.9000 (-14.80%)
COLL : 29.83 (+0.78%)
EBS : 6.22 (-1.43%)
TEVA : 16.95 (-0.64%)
PFE : 23.97 (+0.38%)
Abuse Deterrent Formulations Market Exploding While Estimated to Reach $39 Million In 2025 and $54 Million By 2030

NTRB : 7.79 (unch)
NTRBW : 1.9000 (-14.80%)
COLL : 29.83 (+0.78%)
EBS : 6.22 (-1.43%)
TEVA : 16.95 (-0.64%)
PFE : 23.97 (+0.38%)
Collegium to Participate in Upcoming Investor Conferences

COLL : 29.83 (+0.78%)
Collegium Announces $25 Million Accelerated Share Repurchase Program

COLL : 29.83 (+0.78%)
Collegium Pharmaceutical: Q1 Earnings Snapshot

Collegium Pharmaceutical: Q1 Earnings Snapshot

COLL : 29.83 (+0.78%)
Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress

COLL : 29.83 (+0.78%)
3 Healthcare Stocks That Concern Us

3 Healthcare Stocks That Concern Us

CORT : 71.38 (+0.20%)
COLL : 29.83 (+0.78%)
SEM : 14.84 (-0.54%)
Collegium to Report First Quarter 2025 Financial Results on May 8, 2025

COLL : 29.83 (+0.78%)
2 Reasons to Watch COLL and 1 to Stay Cautious

2 Reasons to Watch COLL and 1 to Stay Cautious

COLL : 29.83 (+0.78%)
A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack

A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack

RPRX : 34.86 (-0.14%)
COLL : 29.83 (+0.78%)
SUPN : 32.28 (-2.06%)
OGN : 9.75 (-1.32%)
ZTS : 157.17 (+1.36%)

Business Summary

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171,...

See More

Key Turning Points

3rd Resistance Point 30.85
2nd Resistance Point 30.41
1st Resistance Point 30.12
Last Price 29.83
1st Support Level 29.39
2nd Support Level 28.95
3rd Support Level 28.66

See More

52-Week High 42.29
Fibonacci 61.8% 35.01
Fibonacci 50% 32.76
Fibonacci 38.2% 30.51
Last Price 29.83
52-Week Low 23.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar